Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Trump vs. Harris: How Could the US Election Affect the Gold Price?

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

A Guide to Investing in Physical Gold (Updated 2024)

How Will the US Election Affect the Crypto Industry?

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Should You Invest in Silver Bullion? (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Trending Press Releases

Argentina Lithium Announces Receipt of Drill Permit for the Paso de Sico Property at its Rincon West Lithium Project

Astral’s Group Gold Mineral Resource Increases to 1.46Moz with Updated Feysville MRE

New Exceptionally High-Grade Gold Intersections from Infill Drilling at Crown Prince

Ashburton Mineralisation Expands as Project Delivers Wide and High-grade Uranium Drill Results

Lode Gold Submits Application for Exchange Approval to Form Spin Co, Gold Orogen - a Yukon & New Brunswick Exploration Company

Brunswick Exploration Discovers Greenland's First Spodumene Pegmatite in Major Evolved Pegmatite Field

More Press Releases
Trending Companies

Controlled Thermal Resources

Falco Resources

FPC:CC

Red Metal Resources

RMES:CC

Mawson Finland Limited

MFL:CC
More Companies
Trending Reports

2024 Lithium Market Outlook

2024 Gold Outlook Report

2024 Copper Outlook Report

2024 Life Science Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Bristol-Myers Squibb

NYSE:BMY
Press Releases

Bristol Myers Squibb Reports First Quarter Financial Results for 2023

Bristol Myers Squibb Announces Leadership Transition Plan

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Interactive Chart

×